| CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p/miR-183-5p-XIAP axis |
35 |
| An inflammatory environment containing TNF alpha favors Tet2-mutant clonal hematopoiesis |
23 |
| Venetoclax: A new wave in hematooncology |
15 |
| Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients |
14 |
| Megakaryocyte and polyploidization |
14 |
| RUNX1 and the endothelial origin of blood |
13 |
| The Human Cell Atlas bone marrow single-cell interactive web portal |
12 |
| Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study |
11 |
| Development of innate immune cells from human pluripotent stem cells |
11 |
| Hematopoietic stem cell fate through metabolic control |
9 |
| Biological implications of clonal hematopoiesis |
9 |
| Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic silencing of p15 |
9 |
| miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11 |
8 |
| Circulating tumor DNA in blood: Future genomic biomarkers for cancer detection |
7 |
| Increased platelet function during frailty |
6 |
| Branched-chain amino acid depletion conditions bone marrow for hematopoietic stem cell transplantation avoiding amino acid imbalance-associated toxicity |
6 |
| MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease |
6 |
| Many layers of embryonic hematopoiesis: new insights into B-cell ontogeny and the origin of hematopoietic stem cells |
6 |
| A track of the clones: new developments in cellular barcoding |
6 |
| A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia |
6 |
| BTLA marks a less cytotoxic T-cell subset in diffuse large B-cell lymphoma with high expression of checkpoints |
5 |
| Scriptaid inhibits cell survival, cell cycle, and promotes apoptosis in multiple myeloma via epigenetic regulation of p21 |
5 |
| KLF1 mutation E325K induces cell cycle arrest in erythroid cells differentiated from congenital dyserythropoietic anemia patient-specific induced pluripotent stem cells |
5 |
| Eltrombopag promotes DNA repair in human hematopoietic stem and progenitor cells |
5 |
| Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia |
5 |
| Human acute myeloid leukemia blast-derived exosomes in patient-derived xenograft mice mediate immune suppression |
5 |
| CD123 CAR T cells for the treatment of myelodysplastic syndrome |
5 |
| Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation |
5 |
| MISTRG mice support engraftment and assessment of nonhuman primate hematopoietic stem and progenitor cells |
5 |
| Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34(+)CD38(-) cells through iron chelation, induction of ROS, and inhibition of HIF1 alpha expression |
5 |
| MicroRNA-155 expression and function in AML: An evolving paradigm |
5 |
| Membrane-potential compensation reveals mitochondrial volume expansion during HSC commitment |
5 |
| Arterial identity of hemogenic endothelium: a key to unlock definitive hematopoietic commitment in human pluripotent stem cell cultures |
4 |
| Philadelphia-like acute lymphoblastic leukemia: diagnostic dilemma and management perspectives |
4 |
| Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma |
4 |
| Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34(+) cells preceding leukemic transformation |
4 |
| CTLA4Ig-based reduced intensity conditioning and donor lymphocyte infusions for haploidentical transplantation in refractory aggressive B-cell lymphoma relapsing after an autograft: Early results from a pilot study |
4 |
| The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation |
4 |
| Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice |
4 |
| Mesenchymal stromal cells induce a permissive state in the bone marrow that enhances G-CSF-induced hematopoietic stem cell mobilization in mice |
4 |
| Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation |
4 |
| Modeling myeloid malignancies with patient-derived iPSCs |
4 |
| Loss of EfnB1 in the osteogenic lineage compromises their capacity to support hematopoietic stem/progenitor cell maintenance |
4 |
| Elevated serum lncRNA TUG1 levels are a potential diagnostic biomarker of multiple myeloma |
4 |
| Sphingosine-1-phosphate signaling modulates terminal erythroid differentiation through the regulation of mitophagy |
4 |
| The BMP pathway: A unique tool to decode the origin and progression of leukemia |
4 |
| Human erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation |
4 |
| RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes |
3 |
| Indirubin regulates MPL and TNF expression in peripheral blood mononuclear cells from patients with primary immune thrombocytopenia |
3 |
| Mechanisms underlying the heterogeneity of myelodysplastic syndromes |
3 |
